The Correlation between Chemical Structures and Antioxidant, Prooxidant, and Antitrypanosomatid Properties of Flavonoids

Oxidative Medicine and Cellular Longevity

Volumn 2017, Issue , 2017, Pages

  Baldim, João Luiz ^a   Alcantara, Bianca Goncalves Vasconcelos De ^a   Domingos, Olívia Da Silva ^a   Soares, Marisi Gomes ^a   Caldas, Ivo Santana ^a   Novaes, Rômulo Dias ^a   Oliveira, Tiago Branquinho ^c   Lago, João Henrique Ghilardi ^b   Chagas Paula, Daniela Aparecida ^a  

^a FEDERAL UNIVERSITY OF ALFENAS   (Brazil)

^b UNIVERSIDADE FEDERAL DO ABC   (Brazil)

^c FEDERAL UNIVERSITY OF SERGIPE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANTS; CHEMOTHERAPY; COMPUTATIONAL CHEMISTRY; MOLECULAR GRAPHICS;

ANTI-OXIDANT ACTIVITIES; DRUG RESISTANCE; EFFICIENT TREATMENT; INTEGRATED NETWORKS; PRO-OXIDANT PROPERTIES; PROOXIDANT; STRUCTURE AND ACTIVITIES; THERAPEUTIC STRATEGY;

FLAVONOIDS;

APIGENIN; ASTRAGALIN; BIOCHANIN A; CHRYSIN; DAIDZEIN; DIOSMETIN; ERIODICTYOL; FISETIN; FLAVONE; FLAVONOID; GALANGIN; GENISTEIN; HESPERIDIN; HYPERIN; ISORHAMNETIN; KAEMPFEROL; LUTEOLIN; LUTEOLIN 7 GLUCOSIDE; MEGLUMINE ANTIMONATE; MORIN; MYRICETIN; NARINGENIN; NICOTIFLORIN; QUERCETIN; QUERCITRIN; RHAMNETIN; RUTOSIDE; STIBOGLUCONATE SODIUM; UNINDEXED DRUG; VITEXIN; ANTIOXIDANT; ANTITRYPANOSOMAL AGENT;

AFRICAN TRYPANOSOMIASIS; ANTIOXIDANT ACTIVITY; ANTITRYPANOSOMATID ACTIVITY; ARTICLE; CHAGAS DISEASE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG STRUCTURE; LEISHMANIA; LEISHMANIASIS; NONHUMAN; PROOXIDANT ACTIVITY; QUANTITATIVE STRUCTURE ACTIVITY RELATION; TRYPANOSOMA; TRYPANOSOMIASIS; BIOLOGICAL MODEL; CHEMISTRY; GROWTH, DEVELOPMENT AND AGING; STRUCTURE ACTIVITY RELATION; TRYPANOSOMA CRUZI;

ANTIOXIDANTS; DRUGS; FLAVONOIDS;

ANTIOXIDANTS; FLAVONOIDS; LEISHMANIA; MODELS, BIOLOGICAL; STRUCTURE-ACTIVITY RELATIONSHIP; TRYPANOCIDAL AGENTS; TRYPANOSOMA CRUZI;

EID: 85024476703     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2017/3789856     Document Type: Article

References (57)

1. C. B. Moraes and C. H. Franco, "Novel drug discovery for Chagas disease," Expert Opinion on Drug Discovery, vol. 11, no. 5, pp. 447-455, 2016.
2. N. Robledo-O'Ryan, M. J. Matos, S. Vazquez-Rodriguez et al., "Synthesis, antioxidant and antichagasic properties of a selected series of hydroxy-3-arylcoumarins," Bioorganic & Medicinal Chemistry, vol. 25, no. 2, pp. 621-632, 2017.
3. M. F. Beer, F. M. Frank, O. G. Elson et al., "Trypanocidal and leishmanicidal activities of flavonoids isolated from Stevia satureiifolia var. satureiifolia," Pharmaceutical Biology, vol. 54, no. 10, pp. 2188-2195, 2016.
4. A. Machado-Silva, P. G. Cerqueira, V. Grazielle-Silva et al., "How Trypanosoma cruzi deals with oxidative stress: Antioxidant defence and DNA repair pathways," Mutation Research, Reviews in Mutation Research, vol. 767, pp. 8-22, 2016.
5. Y. N. Sun, J. H. No, G. Y. Lee et al., "Phenolic constituents of medicinal plants with activity against Trypanosoma brucei," Molecules, vol. 21, no. 480, pp. 1-10, 2016.
6. D. R. Cullen, J. Pengon, R. Rattanajak, J. Chaplin, S. Kamchonwongpaisan, and M. Mocerino, "Scoping studies into the structure-activity relationship (SAR) of phenylephrine-derived analogues as inhibitors of Trypanosoma brucei rhodesiense," ChemistrySelect, vol. 1, no. 15, pp. 4533-4538, 2016.
7. G. Lewin, S. Cojean, S. Gupta, A. Verma, S. K. Puri, and P. M. Loiseau, "In vitro antileishmanial properties of new flavonoids against Leishmania donovani," Biomedicine & Preventive Nutrition, vol. 1, no. 3, pp. 168-171, 2011.
8. D. Kerboeuf, M. Riou, and F. Guégnard, "Flavonoids and related compounds in parasitic disease control," Mini Reviews in Medicinal Chemistry, vol. 8, no. 2, pp. 116-128, 2008.
9. R. L. Krauth-Siegel and G. H. Coombs, "Enzymes of parasite thiol metabolism as drug targets," Trends in Parasitology, vol. 15, no. 10, pp. 404-409, 1999.
10. M. C. Paes, D. Cosentino-Gomes, C. F. de Souza, N. P. Nogueira, and J. R. Meyer-Fernandes, "The role of heme and reactive oxygen species in proliferation and survival of Trypanosoma cruzi," Journal of Parasitology Research, vol. 2011, Article ID 174614, 8 pages, 2011.
11. G. Cao, E. Sofic, and R. L. Prior, "Antioxidant and prooxidant behavior of flavonoids: structure-activity relationships," Free Radical Biology & Medicine, vol. 22, no. 5, pp. 749-760, 1997.
12. P. G. Pietta, "Flavonoids as antioxidants," Journal of Natural Products, vol. 63, no. 7, pp. 1035-1042, 2000.
13. M. Carocho and I. C. F. R. Ferreira, "A review on antioxidants, prooxidants and related controversy: natural and synthetic compounds, screening and analysis methodologies and future perspectives," Food and Chemical Toxicology, vol. 51, no. 1, pp. 15-25, 2013.
14. G. Galati and P. J. O'Brien, "Potential toxicity of flavonoids and other dietary phenolics: significance for their chemopreventive and anticancer properties," Free Radical Biology & Medicine, vol. 37, no. 3, pp. 287-303, 2004.
15. M. Kessler, G. Ubeaud, and L. Jung, "Anti-and pro-oxidant activity of rutin and quercetin derivatives," The Journal of Pharmacy and Pharmacology, vol. 55, no. 1, pp. 131-142, 2003.
16. Z. Markovi, D. Milenkovi, J. orovi et al., "Free radical scavenging activity of morin 2-O() phenoxide anion," Food Chemistry, vol. 135, no. 3, pp. 2070-2077, 2012.
17. E. Middleton, C. Kandaswami, and T. C. Theoharides, "The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer," Pharmacological Reviews, vol. 52, no. 4, pp. 673-751, 2000.
18. J. L. B. Zanin, M. Massoni, M. H. dos Santos et al., "Caesalpinioflavone, a new cytotoxic biflavonoid isolated from Caesalpinia pluviosa var. peltophoroides," Journal of the Brazilian Chemical Society, vol. 26, no. 4, pp. 804-809, 2015.
19. F. Fonseca-Silva, J. D. F. Inacio, M. M. Canto-Cavalheiro, and E. E. Almeida-Amaral, "Reactive oxygen species production and mitochondrial dysfunction contribute to quercetin induced death in Leishmania amazonensis," PloS One, vol. 6, no. 2, pp. 1-7, 2011.
20. G. Sen, S. Mandal, S. S. Roy, S. Mukhopadhyay, and T. Biswas, "Therapeutic use of quercetin in the control of infection and anemia associated with visceral leishmaniasis," Free Radical Biology & Medicine, vol. 38, no. 9, pp. 1257-1264, 2005.
21. D. Tasdemir, M. Kaiser, R. Brun et al., "Antitrypanosomal and antileishmanial activities of flavonoids and their analogues: in vitro, in vivo, structure-activity relationship, and quantitative structure-activity relationship studies," Antimicrobial Agents and Chemotherapy, vol. 50, no. 4, pp. 1352-1364, 2006.
22. M. E. Smoot, K. Ono, J. Ruscheinski, P. L. Wang, and T. Ideker, "Cytoscape 2.8: new features for data integration and network visualization," Bioinformatics, vol. 27, no. 3, pp. 431-432, 2011.
23. C. Perez-Llamas and N. Lopez-Bigas, "Gitools: Analysis and visualisation of genomic data using interactive heat-maps," PloS One, vol. 6, no. 5, pp. 1-6, 2011.
24. C. W. Yap, "PaDEL-descriptor: An open source software to calculate molecular descriptors and fingerprints," Journal of Computational Chemistry, vol. 32, no. 7, pp. 1466-1474, 2011.
25. J. J. P. Stewart, MOPAC 2016, Stewart Computacional Chemistry, Colorado Springs, CO, USA, 2016.
26. J. J. P. Stewart, "Optimization of parameters for semiempirical methods VI: more modifications to the NDDO approximations and re-optimization of parameters," Journal of Molecular Modeling, vol. 19, no. 1, pp. 1-32, 2013.
27. E. Frank, M. A. Hall, and I. H. Witten, The WEKA Workbench. Online Appendix for Data Mining: Practical Machine Learning Tools and Techniques, Morgan Kaufmann, San Francisco, 4th edition, 2016.
28. I. H. Witten, E. Frank, and M. A. Hall, Data Mining Practical Machine Learning Tools and Techniques, Morgan Kaufmann, London, 2011.
29. T. B. Oliveira, L. Gobbo-Neto, T. J. Schmidt, and F. B. Da Costa, "Study of chromatographic retention of natural terpenoids by chemoinformatic tools," Journal of Chemical Information and Modeling, vol. 55, no. 1, pp. 26-38, 2015.
30. V. Sharma and S. Singh, "CFS-SMO based classification of breast density using multiple texture models," Medical & Biological Engineering & Computing, vol. 52, no. 6, pp. 521-529, 2014.
31. H. Li, J. Sun, X. Fan et al., "Considerations and recent advances in QSAR models for cytochrome P450-mediated drug metabolism prediction," Journal of Computer-Aided Molecular Design, vol. 22, no. 11, pp. 843-855, 2008.
32. K. Dhiman and S. M. Agarwal, "NPred: QSAR classification model for identifying plant based naturally occurring anticancerous inhibitors," RSC Advances, vol. 6, no. 55, pp. 49395-49400, 2016.
33. P. Zoumpoulakis, C. Camoutsis, G. Pairas et al., "Synthesis of novel sulfonamide-1,2,4-triazoles, 1,3,4-thiadiazoles and 1,3,4-oxadiazoles, as potential antibacterial and antifungal agents. Biological evaluation and conformational analysis studies," Bioorganic & Medicinal Chemistry, vol. 20, no. 4, pp. 1569-1583, 2012.
34. S. Wyllie, M. L. Cunningham, and A. H. Fairlamb, "Dual action of antimonial drugs on thiol redox metabolism in the human pathogen Leishmania donovani," The Journal of Biological Chemistry, vol. 279, no. 38, pp. 39925-39932, 2004.
35. J. F. Turrens, "Oxidative stress and antioxidant defenses: A target for the treatment of diseases caused by parasitic protozoa," Molecular Aspects of Medicine, vol. 25, no. 1-2, pp. 211-220, 2004.
36. J. D. Maya, S. Bollo, L. J. Nuñez-Vergara et al., "Trypanosoma cruzi: effect and mode of action of nitroimidazole and nitrofuran derivatives," Biochemical Pharmacology, vol. 65, no. 6, pp. 999-1006, 2003.
37. P. M. Loiseau and C. Bories, "Mechanisms of drug action and drug resistance in Leishmania as basis for therapeutic target identification and design of antileishmanial modulators," Current Topics in Medicinal Chemistry, vol. 6, no. 5, pp. 539-550, 2006.
38. D. Procházková, I. Boušová, and N. Wilhelmová, "Antioxidant and prooxidant properties of flavonoids," Fitoterapia, vol. 82, no. 4, pp. 513-523, 2011.
39. W. Bors, W. Heller, C. Michel, and M. Saran, "Flavonoids as antioxidants: determination of radical-scavenging efficiencies," Methods in Enzymology, vol. 186, pp. 343-355, 1990.
40. D. Ami, D. Davidovi-Ami, D. Beslo, V. Rastija, B. Luci, and N. Trinajsti, "SAR and QSAR of the antioxidant activity of flavonoids," Current Medicinal Chemistry, vol. 14, no. 7, pp. 827-845, 2007.
41. C. M. Ribeiro, P. Budni, R. C. Pedrosa et al., "Antioxidant therapy attenuates oxidative insult caused by benzonidazole in chronic Chagas' heart disease," International Journal of Cardiology, vol. 145, no. 1, pp. 27-33, 2010.
42. M. Keenan and J. H. Chaplin, "A new era for Chagas disease drug discovery" Progress in Medicinal Chemistry, vol. 54, pp. 185-230, 2015.
43. P. Polishchuk, O. Tinkov, T. Khristova et al., "Structural and physico-chemical interpretation (SPCI) of QSAR models and its comparison with matched molecular pair analysis," Journal of Chemical Information and Modeling, vol. 56, no. 8, pp. 1455-1469, 2016.
44. B. F. Rasulev, N. D. Abdullaev, V. N. Syrov, and J. Leszczynski, "A quantitative structure-activity relationship (QSAR) study of the antioxidant activity of flavonoids," QSAR and Combinatorial Science, vol. 24, no. 9, pp. 1056-1065, 2005.
45. D. A. Chagas-Paula, T. B. Oliveira, T. Zhang, R. Edrada-Ebel, and F. B. Da Costa, "Prediction of anti-inflammatory plants and discovery of their biomarkers by machine learning algorithms and metabolomic studies," Planta Medica, vol. 81, no. 6, pp. 450-458, 2015.
46. D. L. J. Alexander, A. Tropsha, and D. A. Winkler, "Beware of R2: simple, unambiguous assessment of the prediction accuracy of QSAR and QSPR models," Journal of Chemical Information and Modeling, vol. 55, no. 7, pp. 1316-1322, 2015.
47. A. Golbraikh and A. Tropsha, "Beware of q2!," Journal of Molecular Graphics & Modelling, vol. 20, no. 4, pp. 269-276, 2002.
48. L. H. Hall and L. B. Kier, "Electrotopological state indices for atom types: A novel combination of electronic, topological, and valence state information," Journal of Chemical Information and Modeling, vol. 35, no. 6, pp. 1039-1045, 1995.
49. Z. Markovi, D. Milenkovi, J. orovi et al., "PM6 and DFT study of free radical scavenging activity of morin," Food Chemistry, vol. 134, no. 4, pp. 1754-1760, 2012.
50. K. E. Heim, A. R. Tagliaferro, and D. J. Bobilya, "Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships," The Journal of Nutritional Biochemistry, vol. 13, no. 10, pp. 572-584, 2002.
51. K. Ishige, D. Schubert, and Y. Sagara, "Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms," Free Radical Biology & Medicine, vol. 30, no. 4, pp. 433-446, 2001.
52. R. P. Pandey, N. Koirala, J. H. Lee, H. C. Lee, and J. K. Sohng, "Comparative study of the antioxidative potential of common natural flavonoids and isoflavonoids," Microbiology and Biotechnology Letters, vol. 41, no. 3, pp. 367-371, 2013.
53. E. J. Lien, S. Ren, H. H. Bui, and R. Wang, "Quantitative structure-activity relationship analysis of phenolic antioxidants," Free Radical Biology & Medicine, vol. 26, no. 3-4, pp. 285-294, 1999.
54. N. J. Miller and M. B. Ruiz-Larrea, "Flavonoids and other plant phenols in the diet: Their significance as antioxidants," Journal of Nutritional and Environmental Medicine, vol. 12, no. 1, pp. 39-51, 2002.
55. D. Ami, B. Luci, and B. Lui, "Reliability of bond dissociation enthalpy calculated by the PM6 method and experimental TEAC values in antiradical QSAR of flavonoids," Bioorganic & Medicinal Chemistry, vol. 18, no. 1, pp. 28-35, 2010.
56. K. Csepregi, S. Neugart, M. Schreiner, and É. Hideg, "Comparative evaluation of total antioxidant capacities of plant polyphenols," Molecules, vol. 21, no. 2, pp. 1-17, 2016.
57. C. A. Rice-Evans and N. J. Miller, "Antioxidant activities of flavonoids as bioactive components of food," Biochemical Society Transactions, vol. 24, no. 3, pp. 790-795, 1996.